Saint Louis University

Aarthi Pauldass, a graduate student in the Department of Nutrition and Dietetics is completing her research thesis on the effects of Indian gooseberries on improving blood glucose and cholesterol levels.

Indian Gooseberry is a fruit that is native to India and grows in the tropical and subtropical regions. It has been found to have various health benefits that include improving the blood glucose and blood cholesterol levels.

This research will study the acceptability of Indian Gooseberries in a healthy adult population in the United States and also its effect on the blood glucose levels. Differences in the weight and body fat percentage will also be measured.

You cannot take part in this study if you are:

  • Less than 18years of age or over 90 years of age
  • Weigh less than 110 poinds
  • Currently pregnant
  • Taking/taken Indian Gooseberry in any form
  • Diagnosed with diabetes
  • Taking medication or supplements that lowers blood cholesterol and blood glucose levels
  • Identified to be medically at risk for any health condition
  • Have hemophilia

If you agree to participate, you will be asked to read and sign the informed consent and HIPAA authorization form and return it tot he principal investigator and then you will be given a screening questionnaire to fill out to determine eligibility. If you are eligible, you will be given two packets of sugar (75g each) to consume when you come for the screening two times during the study, once at the beginning and once at the end of the study period which is after 30 days. You will be asked to schedule an appointment and come for screening to measure your blood glucose level using finger stick test, body weight and body fat percentage. The screening tests will take place in the Exercise Physiology Lab in the Allied Health Building at Saint Louis University. This study will be a randomized control trial including two groups, experimental group and the control group. The supplement will be given to you based on the group you are assigned to. You will be asked to consume the given powder for 30 days. The final visit for screening will be on the 31st day. When you come for the final screening, you will also be asked to fill out an acceptability questionnaire. Hence, the duration of this study will be 31 days.

Participation is voluntary. You may withdraw from the study at any time and this would not affect your care in any way. The information you provide will be kept confidential. It will not include your name or any other identifying information and the information will not be shared to anyone outside of the research team.

If you are willing to participate in this study, please email Aarthi Pauldass at